Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 3
2003 5
2004 6
2005 3
2006 2
2007 6
2008 10
2009 6
2010 4
2011 5
2012 5
2013 8
2014 8
2015 7
2016 6
2017 6
2018 6
2019 11
2020 14
2021 11
2022 12
2023 6
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

140 results

Results by year

Filters applied: . Clear all
Page 1
Multimodal stimulation screens reveal unique and shared genes limiting T cell fitness.
Lin CP, Levy PL, Alflen A, Apriamashvili G, Ligtenberg MA, Vredevoogd DW, Bleijerveld OB, Alkan F, Malka Y, Hoekman L, Markovits E, George A, Traets JJH, Krijgsman O, van Vliet A, Poźniak J, Pulido-Vicuña CA, de Bruijn B, van Hal-van Veen SE, Boshuizen J, van der Helm PW, Díaz-Gómez J, Warda H, Behrens LM, Mardesic P, Dehni B, Visser NL, Marine JC, Markel G, Faller WJ, Altelaar M, Agami R, Besser MJ, Peeper DS. Lin CP, et al. Among authors: markel g. Cancer Cell. 2024 Apr 8;42(4):623-645.e10. doi: 10.1016/j.ccell.2024.02.016. Epub 2024 Mar 14. Cancer Cell. 2024. PMID: 38490212 Free PMC article.
Gender Gap in Leadership of Clinical Trials.
Waldhorn I, Bomze D, Ben-Aharon I, Schlosser S, Markel G, Ludmir EB, Meirson T. Waldhorn I, et al. Among authors: markel g. JAMA Intern Med. 2023 Dec 1;183(12):1406-1408. doi: 10.1001/jamainternmed.2023.5104. JAMA Intern Med. 2023. PMID: 37902723
MYC Induces Immunotherapy and IFNγ Resistance Through Downregulation of JAK2.
Markovits E, Harush O, Baruch EN, Shulman ED, Debby A, Itzhaki O, Anafi L, Danilevsky A, Shomron N, Ben-Betzalel G, Asher N, Shapira-Frommer R, Schachter J, Barshack I, Geiger T, Elkon R, Besser MJ, Markel G. Markovits E, et al. Among authors: markel g. Cancer Immunol Res. 2023 Jul 5;11(7):909-924. doi: 10.1158/2326-6066.CIR-22-0184. Cancer Immunol Res. 2023. PMID: 37074069
First-line programmed death-1 inhibitor treatment for locoregionally advanced or metastatic cutaneous squamous cell carcinoma - A real-world experience from Israel.
Averbuch I, Salman S, Shtamper N, Doweck I, Popovtzer A, Markel G, Hendler D, Finkel I, Moore A, Fenig E, Taha T, Mhameed K, Kurman N, Billan S. Averbuch I, et al. Among authors: markel g. Front Oncol. 2023 Jan 26;13:1117804. doi: 10.3389/fonc.2023.1117804. eCollection 2023. Front Oncol. 2023. PMID: 36793605 Free PMC article.
Systemic review of the robustness of randomized controlled trials for the treatment of cholangiocarcinoma in three domains: survival-inferred fragility index, restricted mean survival time, and the spin effect.
Horesh N, Bomze D, Lim C, Markel G, Meirson T, Azoulay D. Horesh N, et al. Among authors: markel g. Hepatobiliary Surg Nutr. 2022 Dec;11(6):861-869. doi: 10.21037/hbsn-21-118. Hepatobiliary Surg Nutr. 2022. PMID: 36523938 Free PMC article. Review.
140 results